COVID-19: loss of bridging between innate and adaptive immunity?

dc.creatorRao, Vishal U. S.
dc.creatorArakeri, Gururaj
dc.creatorSubash, Anand
dc.creatorRao, Jyothsna
dc.creatorJadhav, Sachin
dc.creatorSuhail Sayeed, Mufti
dc.creatorRao, Gururaj
dc.creatorBrennan, Peter A.
dc.date.accessioned2020-06-22T19:04:31Z
dc.date.available2020-06-22T19:04:31Z
dc.date.issued2020-11
dc.description.abstractCOVID-19 has spread to most countries in the world. However, there are some striking differences in how COVID-19 is behaving in different age groups. While data on COVID-19 is limited, children appear to be less susceptible to severe disease. These unique characteristics may be considered as a potential link to understanding the immune system and response in COVID-19 and lead to an effective cure to the disease. We suggest a possible role of loss of bridging between innate and adaptive immunity in COVID-19 and a potential treatment modality also discussed.pt_BR
dc.identifier.citationRAO, V. U. S. et al. COVID-19: loss of bridging between innate and adaptive immunity? Medical Hypotheses, [S.l.], v. 144, Nov. 2020.pt_BR
dc.identifier.urihttps://repositorio.ufla.br/handle/1/41524
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S030698772030863Xpt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsopenAccesspt_BR
dc.sourceMedical Hypothesespt_BR
dc.subjectCOVID-19pt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)pt_BR
dc.subjectAdaptive immunitypt_BR
dc.subjectInnate immunitypt_BR
dc.subjectCytokinespt_BR
dc.subjectInterferons (IFNs)pt_BR
dc.titleCOVID-19: loss of bridging between innate and adaptive immunity?pt_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
953 B
Formato:
Item-specific license agreed upon to submission
Descrição: